Aruvant Sciences Is A Clinical Stagebiopharmaceutical Company Based In New Yorkspecializing In Genetherapies For Rarehematological Conditionsfounded In 2018 In Collaboration With Cincinnati Childrenaes Hospital Medical Centeraruvant Is Part Of Theroivant Family Of Companies Thecompany Is Focused On Developing Innovativegenetherapieswith Its Lead Product Candidatearu 1801Aimed At Treating Sicklecell Diseasescd This Investigational Lentiviral Genetherapy Modifies Autologous Cells To Producea Potent Anti Sickling I Globinoffering A Potentially Curativeonetimetreatmentaruvant Is Currently Conducting Phase1 2 Clinical Trials For Aru 1801 And Plans To Expand Its Research To Includei Thalassemiathecompany Collaborates With Various Research Institutions And Biotech Firms To Advanceits Programswill Chou Is Theceo Of Aruvant Sciences
